Camrelizumab plus platinum-irinotecan followed by maintenance camrelizumab plus apatinib in untreated extensive-stage small-cell lung cancer: a nonrandomized clinical trial

por Ni, Jun, Si, Xiaoyan, Wang, Hanping, Zhang, Xiaotong, Zhang, Li
Publicado 2023

Savolitinib versus crizotinib for treating MET positive non‐small cell lung cancer

por Miao, Kang, Zhang, Xiaotong, Wang, Hanping, Si, Xiaoyan, Zhang, Li
Publicado 2023

Re-biopsy status among Chinese non-small-cell lung cancer patients who progressed after icotinib therapy

por Wang, Hanping, Zhang, Li, Si, Xiaoyan, Zhang, Xiaotong, Wang, Mengzhao
Publicado 2018

Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery fro...

por Wang, Hanping, Zhang, Li, Shi, Xiaohua, Zhang, Xiaotong, Si, Xiaoyan
Publicado 2019

Histologic transformation of lung cancer during pembrolizumab therapy: A case report

por Si, Xiaoyan, You, Yan, Zhang, Xiaotong, Wang, Hanping, Wang, Mengzhao, Zhang, Li
Publicado 2020

Abivertinib in patients with T790M‐positive advanced NSCLC and its subsequent treatment with osimertinib

por Wang, Hanping, Pan, Ruili, Zhang, Xiaotong, Si, Xiaoyan, Wang, Mengzhao, Zhang, Li
Publicado 2020

Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer

por Song, Peng, Zhang, Xiaotong, Yang, Dongliang, Wang, Hanping, Si, Xiaoyan, Zhang, Li
Publicado 2020

Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum‐pemetrexed: The first report of two cases

por Si, Xiaoyan, Wang, Hanping, Zhang, Xiaotong, Wang, Mengzhao, You, Yan, Zhang, Li
Publicado 2020

Multiple infections of zoonotic pathogens in wild Brandt's voles (Lasiopodomys brandtii)

por Guo, Yongman, Li, Zhengrun, Dong, Shike, Si, Xiaoyan, Ta, Na, Liang, Hanwei, Xu, Lei
Publicado 2023

Nimotuzumab combined with chemotherapy as first‐line treatment for advanced lung squamous cell carcinoma

por Si, Xiaoyan, Wu, Shafei, Wang, Hanping, Zhang, Xiaotong, Wang, Mengzhao, Zeng, Xuan, Zhang, Li
Publicado 2018

Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non‐small cell lung cancer patients

por Song, Peng, Yang, Dongliang, Wang, Hanping, Cui, Xiaoxia, Si, Xiaoyan, Zhang, Xiaotong, Zhang, Li
Publicado 2020

Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor‐induced renal immune‐related adverse events

por Zheng, Ke, Qiu, Wei, Wang, Hanping, Si, Xiaoyan, Zhang, Xiaotong, Zhang, Li, Li, Xuemei
Publicado 2020

Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients

por Song, Peng, Yang, Dongliang, Wang, Hanping, Cui, Xiaoxia, Si, Xiaoyan, Zhang, Xiaotong, Zhang, Li
Publicado 2020

NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score

por Song, Peng, Yang, Dongliang, Cui, Xiaoxia, Wang, Hanping, Si, Xiaoyan, Zhang, Xiaotong, Zhang, Li
Publicado 2020

Use of glucocorticoids in the management of immunotherapy‐related adverse effects

por Wang, Hanping, Zhou, Jiaxin, Guo, Xiaoxiao, Li, Yue, Duan, Lian, SI, Xiaoyan, Zhang, Li
Publicado 2020

Assessment of CD27 expression on T-cells as a diagnostic and therapeutic tool for patients with smear-negative pulmonary tuberculosis

por Xu, Feifan, Zhang, Haiyun, Si, Xiaoyan, Chen, Junlin, Chen, Yuhao, Cui, Xiaopeng, Qin, Yongwei
Publicado 2021

EGFR T790M detection in formalin‐fixed paraffin‐embedded tissues of patients with lung cancer using RNA‐based in situ hybridization: A preliminary feasibility study

por Wu, Shafei, Shi, Xiaohua, Si, Xiaoyan, Liu, Yuanyuan, Lu, Tao, Zhang, Li, Liang, Zhiyong, Zeng, Xuan
Publicado 2019

Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity

por Guo, Xiaoxiao, Wang, Hanping, Zhou, Jiaxin, Li, Yue, Duan, Lian, Si, Xiaoyan, Zhang, Li, Fang, Ligang, Zhang, Li
Publicado 2019

Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events

por Song, Peng, Wang, Hanping, Si, Xiaoyan, Guo, Xiaoxiao, Li, Yue, Zhou, Jiaixin, Duan, Lian, Zhang, Li, Wang, Mengzhao
Publicado 2020

Clinical characteristics and prognostic model for extensive‐stage small cell lung cancer: A retrospective study over an 8‐year period

por Ni, Jun, Zhang, Xiaotong, Wang, Hanping, Si, Xiaoyan, Xu, Yan, Zhao, Jing, Chen, Minjiang, Zhang, Li, Wang, Mengzhao
Publicado 2021